News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Arrowhead Pharmaceuticals, Inc.
NEWS
JOBS
IN THE PRESS
NEWS
Drug Development
How Ionis Pharma is Beating the Pants Off of Competitors Like Alnylam, Arrowhead Pharma and Moderna
September 20, 2016
·
2 min read
Deals
Promising Hep B Drug Makes SoCal’s Arrowhead Pharma a Pretty Target for Gilead and Other Big Companies
April 15, 2016
·
2 min read
Deals
Novartis AG Unloads RNAi Portfolio to Arrowhead Research Corporation for $35 Million
March 5, 2015
·
3 min read
Deals
Arrowhead Research Corporation Soars on Rumor of Gilead Sciences, Inc.'s Interest
December 31, 2014
·
2 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
Arrowhead Pharmaceuticals Receives Marketing Authorization in the European Union for REDEMPLO® (plozasiran) to Reduce Triglycerides in Adults with Familial Chylomicronemia Syndrome (FCS)
June 23, 2026
·
9 min read
Press Releases
Arrowhead Pharmaceuticals to Host a Webinar on its Cardiometabolic Pipeline as Part I of the 2026 Summer Series of R&D Webinars
June 19, 2026
·
5 min read
Press Releases
Arrowhead Pharmaceuticals to Participate in Upcoming June 2026 Events
June 2, 2026
·
4 min read
Press Releases
Arrowhead Pharmaceuticals Presents New Clinical Data on RNAi-based Obesity and MASH Candidate ARO-INHBE at EASL 2026
May 27, 2026
·
7 min read
Press Releases
Arrowhead Pharmaceuticals Presents New Positive Clinical Cardiometabolic Data at the 94th European Atherosclerosis Society (EAS) Congress
May 26, 2026
·
8 min read
Press Releases
Arrowhead Pharmaceuticals Reports Fiscal 2026 Second Quarter Results
May 8, 2026
·
13 min read
Press Releases
Arrowhead Pharmaceuticals Licenses Clinical MASH Program Targeting PNPLA3 to Madrigal Pharmaceuticals
May 5, 2026
·
6 min read
Press Releases
Arrowhead Pharmaceuticals to Participate in Upcoming May 2026 Events
May 4, 2026
·
5 min read
Press Releases
Arrowhead Pharmaceuticals Receives TGA Approval of REDEMPLO® (plozasiran) in Australia, Expanding Global Access for Patients with Familial Chylomicronemia Syndrome (FCS)
May 1, 2026
·
10 min read
Press Releases
Arrowhead Pharmaceuticals Receives Positive CHMP Opinion Recommending Approval of REDEMPLO® (plozasiran) to Reduce Triglycerides in Adults with Familial Chylomicronemia Syndrome (FCS) in Europe
April 24, 2026
·
10 min read
